Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Bátkai S[au]:

MicroRNAs in right ventricular remodelling. Batkai S et al. Cardiovasc Res. (2017)

Long noncoding RNA Chast promotes cardiac remodeling. Viereck J et al. Sci Transl Med. (2016)

Inhibition of the Cardiac Fibroblast-Enriched lncRNA <i>Meg3</i> Prevents Cardiac Fibrosis and Diastolic Dysfunction. Piccoli MT et al. Circ Res. (2017)

Search results

Items: 1 to 50 of 116

1.

Circulating microRNA-132 levels improve risk prediction for heart failure hospitalization in patients with chronic heart failure.

Masson S, Batkai S, Beermann J, Bär C, Pfanne A, Thum S, Magnoli M, Balconi G, Nicolosi GL, Tavazzi L, Latini R, Thum T.

Eur J Heart Fail. 2018 Jan;20(1):78-85. doi: 10.1002/ejhf.961. Epub 2017 Oct 12.

PMID:
29027324
2.

Porcine model of progressive cardiac hypertrophy and fibrosis with secondary postcapillary pulmonary hypertension.

Gyöngyösi M, Pavo N, Lukovic D, Zlabinger K, Spannbauer A, Traxler D, Goliasch G, Mandic L, Bergler-Klein J, Gugerell A, Jakab A, Szankai Z, Toth L, Garamvölgyi R, Maurer G, Jaisser F, Zannad F, Thum T, Bátkai S, Winkler J.

J Transl Med. 2017 Oct 6;15(1):202. doi: 10.1186/s12967-017-1299-0.

3.

MicroRNAs in right ventricular remodelling.

Batkai S, Bär C, Thum T.

Cardiovasc Res. 2017 Oct 1;113(12):1433-1440. doi: 10.1093/cvr/cvx153. Review.

PMID:
28957533
4.

Inhibition of the Cardiac Fibroblast-Enriched lncRNA Meg3 Prevents Cardiac Fibrosis and Diastolic Dysfunction.

Piccoli MT, Gupta SK, Viereck J, Foinquinos A, Samolovac S, Kramer FL, Garg A, Remke J, Zimmer K, Batkai S, Thum T.

Circ Res. 2017 Aug 18;121(5):575-583. doi: 10.1161/CIRCRESAHA.117.310624. Epub 2017 Jun 19.

PMID:
28630135
5.

Novel insight into arrhythmogenic remodeling: a target for reversal.

Batkai S, Foinquinos A.

Hypertens Res. 2017 Jul;40(7):632-634. doi: 10.1038/hr.2017.46. Epub 2017 Apr 6. No abstract available.

PMID:
28381871
6.

MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease.

Hartmann D, Fiedler J, Sonnenschein K, Just A, Pfanne A, Zimmer K, Remke J, Foinquinos A, Butzlaff M, Schimmel K, Maegdefessel L, Hilfiker-Kleiner D, Lachmann N, Schober A, Froese N, Heineke J, Bauersachs J, Batkai S, Thum T.

Circulation. 2016 Dec 13;134(24):1973-1990. Epub 2016 Oct 25.

PMID:
27780851
7.

Preclinical Development of a MicroRNA-Based Therapy for Elderly Patients With Myocardial Infarction.

Gupta SK, Foinquinos A, Thum S, Remke J, Zimmer K, Bauters C, de Groote P, Boon RA, de Windt LJ, Preissl S, Hein L, Batkai S, Pinet F, Thum T.

J Am Coll Cardiol. 2016 Oct 4;68(14):1557-71. doi: 10.1016/j.jacc.2016.07.739.

8.

Long noncoding RNA Chast promotes cardiac remodeling.

Viereck J, Kumarswamy R, Foinquinos A, Xiao K, Avramopoulos P, Kunz M, Dittrich M, Maetzig T, Zimmer K, Remke J, Just A, Fendrich J, Scherf K, Bolesani E, Schambach A, Weidemann F, Zweigerdt R, de Windt LJ, Engelhardt S, Dandekar T, Batkai S, Thum T.

Sci Transl Med. 2016 Feb 17;8(326):326ra22. doi: 10.1126/scitranslmed.aaf1475.

PMID:
26888430
9.

miR-21 promotes fibrosis in an acute cardiac allograft transplantation model.

Gupta SK, Itagaki R, Zheng X, Batkai S, Thum S, Ahmad F, Van Aelst LN, Sharma A, Piccoli MT, Weinberger F, Fiedler J, Heuser M, Heymans S, Falk CS, Förster R, Schrepfer S, Thum T.

Cardiovasc Res. 2016 May 15;110(2):215-26. doi: 10.1093/cvr/cvw030. Epub 2016 Feb 9.

PMID:
26865549
10.

Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis.

Lorenzen JM, Schauerte C, Hübner A, Kölling M, Martino F, Scherf K, Batkai S, Zimmer K, Foinquinos A, Kaucsar T, Fiedler J, Kumarswamy R, Bang C, Hartmann D, Gupta SK, Kielstein J, Jungmann A, Katus HA, Weidemann F, Müller OJ, Haller H, Thum T.

Eur Heart J. 2015 Aug 21;36(32):2184-96. doi: 10.1093/eurheartj/ehv109. Epub 2015 Apr 21.

11.

Zinc-α2-Glycoprotein Exerts Antifibrotic Effects in Kidney and Heart.

Sörensen-Zender I, Bhayana S, Susnik N, Rolli V, Batkai S, Baisantry A, Bahram S, Sen P, Teng B, Lindner R, Schiffer M, Thum T, Melk A, Haller H, Schmitt R.

J Am Soc Nephrol. 2015 Nov;26(11):2659-68. doi: 10.1681/ASN.2014050485. Epub 2015 Mar 18.

12.

Plasma and tissue homoarginine concentrations in healthy and obese humans.

May M, Kayacelebi AA, Batkai S, Jordan J, Tsikas D, Engeli S.

Amino Acids. 2015 Sep;47(9):1847-52. doi: 10.1007/s00726-015-1922-4. Epub 2015 Feb 6.

PMID:
25655383
13.

Antiandrogenic therapy with finasteride attenuates cardiac hypertrophy and left ventricular dysfunction.

Zwadlo C, Schmidtmann E, Szaroszyk M, Kattih B, Froese N, Hinz H, Schmitto JD, Widder J, Batkai S, Bähre H, Kaever V, Thum T, Bauersachs J, Heineke J.

Circulation. 2015 Mar 24;131(12):1071-81. doi: 10.1161/CIRCULATIONAHA.114.012066. Epub 2015 Jan 28.

PMID:
25632043
14.

Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension.

Szekeres M, Nádasy GL, Turu G, Soltész-Katona E, Benyó Z, Offermanns S, Ruisanchez É, Szabó E, Takáts Z, Bátkai S, Tóth ZE, Hunyady L.

Mol Cell Endocrinol. 2015 Mar 5;403:46-56. doi: 10.1016/j.mce.2015.01.012. Epub 2015 Jan 13.

PMID:
25595485
15.

Vascular importance of the miR-212/132 cluster.

Kumarswamy R, Volkmann I, Beermann J, Napp LC, Jabs O, Bhayadia R, Melk A, Ucar A, Chowdhury K, Lorenzen JM, Gupta SK, Batkai S, Thum T.

Eur Heart J. 2014 Dec 1;35(45):3224-31. doi: 10.1093/eurheartj/ehu344. Epub 2014 Sep 12.

PMID:
25217442
16.

Towards novel theranostic approaches in cardiac transplantation medicine.

Batkai S, Thum T.

Eur Heart J. 2014 Dec 1;35(45):3152-4. doi: 10.1093/eurheartj/ehu376. Epub 2014 Aug 31. No abstract available.

PMID:
25176943
17.

MicroRNAs in right ventricular (dys)function (2013 Grover Conference series).

Thum T, Batkai S.

Pulm Circ. 2014 Jun;4(2):185-90. doi: 10.1086/675981. Review.

18.

Trapping of NAPQI, the intermediate toxic paracetamol metabolite, by aqueous sulfide (S²⁻) and analysis by GC-MS/MS.

Trettin A, Batkai S, Thum T, Jordan J, Tsikas D.

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Jul 15;963:99-105. doi: 10.1016/j.jchromb.2014.05.050. Epub 2014 Jun 2.

PMID:
24950097
19.

MicroRNAs play a role in spontaneous recovery from acute liver failure.

John K, Hadem J, Krech T, Wahl K, Manns MP, Dooley S, Batkai S, Thum T, Schulze-Osthoff K, Bantel H.

Hepatology. 2014 Oct;60(4):1346-55. doi: 10.1002/hep.27250. Epub 2014 Aug 25.

PMID:
24913549
20.

Analytical approaches in microRNA therapeutics.

Batkai S, Thum T.

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Aug 1;964:146-52. doi: 10.1016/j.jchromb.2014.03.027. Epub 2014 Apr 15. Review.

PMID:
24908160
21.

LC-MS/MS and GC-MS/MS measurement of plasma and urine di-paracetamol and 3-nitro-paracetamol: proof-of-concept studies on a novel human model of oxidative stress based on oral paracetamol administration.

Trettin A, Modun D, Madunic S, Vukovic J, Radman M, Batkai S, Thum T, Jordan J, Tsikas D.

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 May 15;959:71-81. doi: 10.1016/j.jchromb.2014.03.031. Epub 2014 Apr 2.

PMID:
24768921
22.

Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy.

Bang C, Batkai S, Dangwal S, Gupta SK, Foinquinos A, Holzmann A, Just A, Remke J, Zimmer K, Zeug A, Ponimaskin E, Schmiedl A, Yin X, Mayr M, Halder R, Fischer A, Engelhardt S, Wei Y, Schober A, Fiedler J, Thum T.

J Clin Invest. 2014 May;124(5):2136-46. doi: 10.1172/JCI70577. Epub 2014 Apr 17.

23.

MicroRNA-based therapy in cardiology.

Fiedler J, Batkai S, Thum T.

Herz. 2014 Mar;39(2):194-200. doi: 10.1007/s00059-013-4047-0. Review.

PMID:
24573748
24.

Nitro-oleic acid and epoxy-oleic acid are not altered in obesity and type 2 diabetes.

Tsikas D, Batkai S, Mitschke A, Jordan J, Engeli S.

Cardiovasc Res. 2014 Jun 1;102(3):517-8. doi: 10.1093/cvr/cvu043. Epub 2014 Feb 21. No abstract available.

PMID:
24562766
25.

Clinical evaluation of extracellular ADMA concentrations in human blood and adipose tissue.

May M, Batkai S, Zörner AA, Tsikas D, Jordan J, Engeli S.

Int J Mol Sci. 2014 Jan 17;15(1):1189-200. doi: 10.3390/ijms15011189.

26.

Activation of the miR-17 family and miR-21 during murine kidney ischemia-reperfusion injury.

Kaucsár T, Révész C, Godó M, Krenács T, Albert M, Szalay CI, Rosivall L, Benyó Z, Bátkai S, Thum T, Szénási G, Hamar P.

Nucleic Acid Ther. 2013 Oct;23(5):344-54. doi: 10.1089/nat.2013.0438.

27.

MicroRNA-mediated epigenetic silencing of sirtuin1 contributes to impaired angiogenic responses.

Volkmann I, Kumarswamy R, Pfaff N, Fiedler J, Dangwal S, Holzmann A, Batkai S, Geffers R, Lother A, Hein L, Thum T.

Circ Res. 2013 Sep 27;113(8):997-1003. doi: 10.1161/CIRCRESAHA.113.301702. Epub 2013 Aug 19.

PMID:
23960241
28.

Regulation of cardiac and renal ischemia-reperfusion injury by microRNAs.

Lorenzen JM, Batkai S, Thum T.

Free Radic Biol Med. 2013 Sep;64:78-84. doi: 10.1016/j.freeradbiomed.2013.06.044. Epub 2013 Jul 8. Review.

PMID:
23845966
29.

Enhanced human tissue microdialysis using hydroxypropyl-ß-cyclodextrin as molecular carrier.

May M, Batkai S, Zoerner AA, Tsikas D, Jordan J, Engeli S.

PLoS One. 2013;8(4):e60628. doi: 10.1371/journal.pone.0060628. Epub 2013 Apr 5.

30.

Circulating anandamide and blood pressure in patients with obstructive sleep apnea.

Engeli S, Blüher M, Jumpertz R, Wiesner T, Wirtz H, Bosse-Henck A, Stumvoll M, Batkai S, Pacher P, Harvey-White J, Kunos G, Jordan J.

J Hypertens. 2012 Dec;30(12):2345-51. doi: 10.1097/HJH.0b013e3283591595.

PMID:
23032139
31.

The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy.

Ucar A, Gupta SK, Fiedler J, Erikci E, Kardasinski M, Batkai S, Dangwal S, Kumarswamy R, Bang C, Holzmann A, Remke J, Caprio M, Jentzsch C, Engelhardt S, Geisendorf S, Glas C, Hofmann TG, Nessling M, Richter K, Schiffer M, Carrier L, Napp LC, Bauersachs J, Chowdhury K, Thum T.

Nat Commun. 2012;3:1078. doi: 10.1038/ncomms2090.

32.

Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion: therapeutic potential of mitochondrially targeted antioxidants.

Mukhopadhyay P, Horváth B, Zsengellėr Z, Bátkai S, Cao Z, Kechrid M, Holovac E, Erdėlyi K, Tanchian G, Liaudet L, Stillman IE, Joseph J, Kalyanaraman B, Pacher P.

Free Radic Biol Med. 2012 Sep 1;53(5):1123-38. doi: 10.1016/j.freeradbiomed.2012.05.036. Epub 2012 Jun 6.

33.

Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy.

Rajesh M, Bátkai S, Kechrid M, Mukhopadhyay P, Lee WS, Horváth B, Holovac E, Cinar R, Liaudet L, Mackie K, Haskó G, Pacher P.

Diabetes. 2012 Mar;61(3):716-27. doi: 10.2337/db11-0477. Epub 2012 Feb 7.

34.

Peripheral endocannabinoid microdialysis: in vitro characterization and proof-of-concept in human subjects.

Zoerner AA, Rakers C, Engeli S, Batkai S, May M, Jordan J, Tsikas D.

Anal Bioanal Chem. 2012 Mar;402(9):2727-35. doi: 10.1007/s00216-012-5729-9. Epub 2012 Feb 4.

PMID:
22311425
35.

Stable isotope liquid chromatography-tandem mass spectrometry assay for fatty acid amide hydrolase activity.

Rakers C, Zoerner AA, Engeli S, Batkai S, Jordan J, Tsikas D.

Anal Biochem. 2012 Feb 15;421(2):699-705. doi: 10.1016/j.ab.2011.11.003. Epub 2011 Nov 13.

PMID:
22146559
36.

MicroRNAs in hypertension: mechanisms and therapeutic targets.

Bátkai S, Thum T.

Curr Hypertens Rep. 2012 Feb;14(1):79-87. doi: 10.1007/s11906-011-0235-6. Review.

PMID:
22052337
37.

Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: a comprehensive review from an analytical and biological perspective.

Zoerner AA, Gutzki FM, Batkai S, May M, Rakers C, Engeli S, Jordan J, Tsikas D.

Biochim Biophys Acta. 2011 Nov;1811(11):706-23. doi: 10.1016/j.bbalip.2011.08.004. Epub 2011 Aug 19. Review.

PMID:
21875688
38.

Simultaneous UPLC-MS/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: minimization of matrix-effects, 2AG/1AG isomerization and degradation by toluene solvent extraction.

Zoerner AA, Batkai S, Suchy MT, Gutzki FM, Engeli S, Jordan J, Tsikas D.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Feb 1;883-884:161-71. doi: 10.1016/j.jchromb.2011.06.025. Epub 2011 Jun 22.

PMID:
21752730
39.

Allergen challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma.

Zoerner AA, Stichtenoth DO, Engeli S, Batkai S, Winkler C, Schaumann F, Janke J, Holz O, Krug N, Tsikas D, Jordan J, Hohlfeld JM.

Clin Pharmacol Ther. 2011 Sep;90(3):388-91. doi: 10.1038/clpt.2011.94. Epub 2011 Jun 29. No abstract available.

PMID:
21716266
40.

Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors.

Bátkai S, Mukhopadhyay P, Horváth B, Rajesh M, Gao RY, Mahadevan A, Amere M, Battista N, Lichtman AH, Gauson LA, Maccarrone M, Pertwee RG, Pacher P.

Br J Pharmacol. 2012 Apr;165(8):2450-61. doi: 10.1111/j.1476-5381.2011.01410.x.

41.

A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury.

Horváth B, Magid L, Mukhopadhyay P, Bátkai S, Rajesh M, Park O, Tanchian G, Gao RY, Goodfellow CE, Glass M, Mechoulam R, Pacher P.

Br J Pharmacol. 2012 Apr;165(8):2462-78. doi: 10.1111/j.1476-5381.2011.01381.x.

42.

Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.

Mukhopadhyay P, Rajesh M, Horváth B, Bátkai S, Park O, Tanchian G, Gao RY, Patel V, Wink DA, Liaudet L, Haskó G, Mechoulam R, Pacher P.

Free Radic Biol Med. 2011 May 15;50(10):1368-81. doi: 10.1016/j.freeradbiomed.2011.02.021. Epub 2011 Mar 11.

43.

Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.

Rajesh M, Mukhopadhyay P, Bátkai S, Patel V, Saito K, Matsumoto S, Kashiwaya Y, Horváth B, Mukhopadhyay B, Becker L, Haskó G, Liaudet L, Wink DA, Veves A, Mechoulam R, Pacher P.

J Am Coll Cardiol. 2010 Dec 14;56(25):2115-25. doi: 10.1016/j.jacc.2010.07.033.

44.

Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects.

Godlewski G, Alapafuja SO, Bátkai S, Nikas SP, Cinar R, Offertáler L, Osei-Hyiaman D, Liu J, Mukhopadhyay B, Harvey-White J, Tam J, Pacak K, Blankman JL, Cravatt BF, Makriyannis A, Kunos G.

Chem Biol. 2010 Nov 24;17(11):1256-66. doi: 10.1016/j.chembiol.2010.08.013.

45.

Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury.

Mukhopadhyay P, Horváth B, Rajesh M, Matsumoto S, Saito K, Bátkai S, Patel V, Tanchian G, Gao RY, Cravatt BF, Haskó G, Pacher P.

Free Radic Biol Med. 2011 Jan 1;50(1):179-95. doi: 10.1016/j.freeradbiomed.2010.11.002. Epub 2010 Nov 9.

46.

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity.

Tam J, Vemuri VK, Liu J, Bátkai S, Mukhopadhyay B, Godlewski G, Osei-Hyiaman D, Ohnuma S, Ambudkar SV, Pickel J, Makriyannis A, Kunos G.

J Clin Invest. 2010 Aug;120(8):2953-66. doi: 10.1172/JCI42551. Epub 2010 Jul 26. Erratum in: J Clin Invest. 2010 Oct 1;120(10):3735.

47.

Measurement and diagnostic use of hepatic cytochrome P450 metabolism of oleic acid in liver disease.

Thum T, Batkai S, Malinski PG, Becker T, Mevius I, Klempnauer J, Meyer HH, Frölich JC, Borlak J, Tsikas D.

Liver Int. 2010 Sep;30(8):1181-8. doi: 10.1111/j.1478-3231.2010.02310.x. Epub 2010 Jul 8.

PMID:
20629947
48.

CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model.

Mukhopadhyay P, Pan H, Rajesh M, Bátkai S, Patel V, Harvey-White J, Mukhopadhyay B, Haskó G, Gao B, Mackie K, Pacher P.

Br J Pharmacol. 2010 Jun;160(3):657-68. doi: 10.1111/j.1476-5381.2010.00769.x.

49.

Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea--specific role of oleoylethanolamide.

Jumpertz R, Wiesner T, Blüher M, Engeli S, Bátkai S, Wirtz H, Bosse-Henck A, Stumvoll M.

Exp Clin Endocrinol Diabetes. 2010 Oct;118(9):591-5. doi: 10.1055/s-0030-1253344. Epub 2010 Apr 28.

PMID:
20429051
50.

Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.

Mukhopadhyay P, Rajesh M, Pan H, Patel V, Mukhopadhyay B, Bátkai S, Gao B, Haskó G, Pacher P.

Free Radic Biol Med. 2010 Feb 1;48(3):457-67. doi: 10.1016/j.freeradbiomed.2009.11.022. Epub 2009 Dec 4.

Supplemental Content

Loading ...
Support Center